Korea to Insure Pfizer’s Xalkori, Significantly Reducing Patients’ Burden

SEOUL, April 20 (Korea Bizwire) – As it is expected that Pfizer’s Xalkori cancer drug will be covered by the national health insurance in Korea, the 10 million won (US$9,225) burden that patients are currently facing will be dramatically reduced starting next month. According to a statement from the Ministry of Health and Welfare and the [...]